Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease

Digestive Diseases and Sciences

Volumn 42, Issue 5, 1997, Pages 1047-1054

  Kimura, Hiroyuki ^b   Miura, Soichiro ^b   Shigematsu, Takeharu ^b   Ohkubo, Nobuyuki ^b   Tsuzuki, Yoshikazu ^b   Kurose, Iwao ^b   Higuchi, Hajime ^b   Akiba, Yasutada ^b   Hokari, Ryota ^b   Hirokawa, Masahiko ^b   Serizawa, Hiroshi ^b   Ishii, Hiromasa ^a  

^a KEIO UNIVERSITY   (Japan)

^b NONE

Author keywords

Crohn's disease; nitric oxide; ulcerative colitis

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ADULT; ANIMAL TISSUE; ARTICLE; COLON MUCOSA; CONTROLLED STUDY; CROHN DISEASE; ENZYME ACTIVITY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADULT; COLITIS, ULCERATIVE; COLON; CROHN DISEASE; ENZYME INDUCTION; FEMALE; HUMANS; INTESTINAL MUCOSA; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

EID: 8244235129     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018849405922     Document Type: Article

References (34)

1. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med 329:2002-2012, 1993
2. Nathan C: Nitric oxide as a secretory product of mammalian cells. FASEB J 6:3051-3064, 1992
3. Stuehr DJ, Nathan CF: Nitric oxide: A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 169:1543-1555, 1989
4. Kurose I, Miura S, Fukumura D, Yonei Y, Saito H, Tada S, Suematsu M, Tsuchiya M: Nitric oxide mediates Kupffer cell-induced reduction of mitochondrial energization in hepatoma cells: A comparison with oxidative burst. Cancer Res 53:2676-2682, 1993
5. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA: Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87:1620-1625, 1990
6. Roediger WEW, Lawson MJ, Radcliffe BC: Nitrite from inflammatory cells: A cancer risk factor in ulcerative colitis? Dis Colon Rectum 33:1034-1036, 1990
7. Middleton SJ, Shorthouse M, Hunter JO: Increased nitric oxide synthesis in ulcerative colitis. Lancet 341:465-466, 1993
8. Miller MJS, Sadowska-Krowicka H, Chotinaruemol S, Kakkis JL, Clark DA: Amelioration of chronic ileitis by nitric oxide synthase inhibition. J Pharmacol Exp Ther 264:11-16, 1993
9. Yamada T, Sartor RB, Marshall S, Specian RD, Grisham MB: Mucosal injury and inflammation in a model of granulomatous colitis in rats. Gastroenterology 104:759-777, 1993
10. Boughton-Smith NK, Evans SM, Hawkey CJ, Cole AT, Balsitis M, Whittle BJR, Moncada S: Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet 342:338-340, 1993
11. Grisham MB, Specian RD, Zimmerman TE: Effects of nitric oxide synthase inhibition on the pathophysiology observed in a model of chronic granulomatous colitis. J Pharmacol Exp Ther 271:1114-1121, 1994
12. Kirsner JB, Shorter RG: Inflammatory Bowel Disease, ed 3. Philadelphia, Lea & Febiger, 1988
13. Rachmilewitz D, Stamler JS, Bachwich D, Karmeli F, Ackerman Z, Podolsky DK: Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut 36:718-723, 1995
14. Hibi T, Ohara M, Kobayashi K, Brown WR, Toda K, Takaishi H, Hosoda Y, Hayashi A, Iwao Y, Watanabe M, Aiso S, Kawai Y, Tsuchiya M: Enzyme linked immunosorbent assay (ELISA) and immunoprecipitation studies on anti-goblet cell antibody using a mucin producing cell line in patients with inflammatory bowel disease. Gut 35:224-230, 1994
15. Best WR, Becktel JM, Singelton JW, Kern F, Jr: Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 70:439-444, 1976
16. Rutegard I, Ahsgren L, Stenling R, Nilsson T: A simple index for assessment of disease activity in patients with ulcerative colitis. Hepatogastroenterology 37:110-112, 1990
17. Wardle TD, Hall L, Turnberg LA: Use of coculture of colonic mucosal biopsies to investigate the release of eicosanoids by inflamed and uninflamed mucosa from patients with inflammatory bowel disease. Gut 33:1644-1651, 1992
18. Granger DL, Hibbs JB Jr, Perfect JR, Durack DT: Metabolic fare of L-arginine in relation to microbiostatic capacity of murine macrophages. J Clin Invest 85:264-273, 1990
19. Knowles RG, Merrett M, Salter M, Moncada S: Differential induction of brain, lung and liver nitric oxide synthase by endotoxin in the rat. Biochem J 270:833-836, 1990
20. Riley SA, Mani V, Goodman MJ, Herd ME, Dutt S, Turnberg LA: Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse. Gut 29:669-674, 1988
21. Grisham MB, Miles AM, Owens M, Johnson GG: Molecular, biochemical and cellular characterization of the inducible nitrite oxide synthase in circulating vs. extravasated polymorphonuclear leukocytes (PMNs). Gastroenterology 106:A693, 1994
22. Sartor RB: Cytokines in intestinal inflammation: Pathophysiological and clinical considerations. Gastroenterology 106:533-539, 1994
23. Tepperman BL, Brown JF, Whittle BJR: Nitric oxide synthase induction and intestinal epithelial cell viability in rats. Am J Physiol 265:G214-G218, 1993
24. 1 generation by cultured small intestinal epithelial cells. Dig Dig Sci 40:1859-1865, 1995
25. Reynolds PD, Middleton SJ, Hunter JO, Facer P, Bishop A, Evans T, Polak JM: High expression of iNOS in colonic mucosa in ulcerative colitis. Gastroenterology 108:A903, 1995
26. Singer H, Kawka DW, Scott S, Weidner JR, Mumford RA, Riehl TE, Stenson WF: Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 111:871-885, 1996
27. Belenky SN, Rohhins RA, Rennard SI, Gossman GL, Nelson KJ, Rubinstein I: Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro. J Lab Clin Med 122:388-394, 1993
28. Belenky SN, Robbins RA, Rubinstein I: Nitric oxide synthase inhibitors attenuate human monocyte chemotaxis in vitro. J Leukoc Biol 53:498-503, 1993
29. Granger DL, Taintor RR, Cook JL, Hibbs JB: Injury of neoplastic cells by murine macrophages leads to inhibition of mitochondrial respiration. J Clin Invest 65:357-370, 1980
30. Hibbs JB, Taintor RR, Vavrin Z: Iron depletion: Possible cause of tumor cell cytotoxicity induced by activated macrophages. Biochem Biophys Res Commun 123:716-723, 1984
31. Kwon NS, Stuehr DJ, Nathan CF: Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide. J Exp Med 174:761-767, 1991
32. Sankey EA, Dhillon AP, Anthony A, Wakefield AJ, Sim R, More L, Hudson M, Sawyerr AM, Pounder RE: Early mucosal changes in Crohn's disease. Gut 34:375-381, 1993
33. Baldassano RN, Schreiber S, Johnston RB Jr, Fu RD, Muraki T, MacDermott RP: Crohn's disease monocytes are primed for accentuated release of toxic oxygen metabolites. Gastroenterology 105:60-66, 1993
34. Suematsu M, Suzuki M, Kitahora T, Miura S, Suzuki K, Hibi T, Watanabe M, Nagata H, Asakura H, Tsuchiya M: Increased respiratory burst of leukocytes in inflammatory bowel diseases - The analysis of free radical generation by using chemiluminescence probe. J Clin Lab Immunol 24:125-128, 1987